How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

70,379 results for

Stimulant Use Disorder

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Treatment of Chronic Back and Chest Pain in a Patient with Sickle Cell Disease Using Spinal Cord Stimulation (Full text)

Treatment of Chronic Back and Chest Pain in a Patient with Sickle Cell Disease Using Spinal Cord Stimulation 29911986 2018 12 07 1308-5263 35 4 2018 Nov 13 Turkish journal of haematology : official journal of Turkish Society of Haematology Turk J Haematol Treatment of Chronic Back and Chest Pain in a Patient with Sickle Cell Disease Using Spinal Cord Stimulation 307-308 10.4274/tjh.2017.0447 Yürük Damla D 0000-0002-0799-3434 Bursa Yüksek İhtisas Training and Research Hospital, Clinic (...) of Algology, Bursa, Turkey Aşık İbrahim İ 0000-0002-5830-5179 Ankara University Faculty of Medicine, Department of Algology, Bursa, Turkey eng Journal Article Orak Hücre Hastasında Kronik Sırt ve Göğüs Ağrısının Spinal Kord Stimülatörü ile Tedavisi 2018 06 18 Turkey Turk J Haematol 9606065 1300-7777 Chronic pain Sickle cell disease Spinal cord stimulation 2018 6 19 6 0 2018 6 19 6 0 2018 6 19 6 0 ppublish 29911986 10.4274/tjh.2017.0447 PMC6256825 Neurosurgery. 2006 Mar;58(3):481-96; discussion 481-96

2018 Turkish Journal of Hematology PubMed abstract

62. Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder

the participant is assigned to the active or sham condition. Primary Purpose: Treatment Official Title: A Double-Blind, Randomized, Controlled Trial, Utilizing Accelerated Repetitive Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Craving in Hospitalized Patients With Opiate Use Disorder Actual Study Start Date : September 28, 2018 Estimated Primary Completion Date : June 1, 2020 Estimated Study Completion Date : June 1, 2020 Resource links provided by the National Library of Medicine (...) Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Repetitive

2018 Clinical Trials

63. A Review of Brain Stimulation Methods to Treat Substance Use Disorders (Full text)

A Review of Brain Stimulation Methods to Treat Substance Use Disorders Substance use disorders (SUDs) are a leading cause of disability worldwide. While several pharmacological and behavioral treatments for SUDs are available, these may not be effective for all patients. Recent studies using non-invasive neuromodulation techniques including Repetitive Transcranial Magnetic Stimulation (rTMS), Transcranial Direct Current Stimulation (tDCS), and Deep Brain Stimulation (DBS) have shown promise (...) similar results. Results are most encouraging when stimulation is targeted to the Dorsolateral Prefrontal Cortex (DLPFC).Short-term treatment with rTMS and tDCS may have beneficial effects on drug craving and consumption. Future studies should focus on extending therapeutic benefits by increasing stimulation frequency and duration of treatment.The utility of these methods in SUD treatment and prevention are unclear, and warrants further study using randomized, controlled designs. (Am J Addict 2018;27

2018 The American Journal on Addictions PubMed abstract

64. Nucleus Accumbens Deep Brain Stimulation in Patients with Substance Use Disorders and Delay Discounting (Full text)

Nucleus Accumbens Deep Brain Stimulation in Patients with Substance Use Disorders and Delay Discounting Deep brain stimulation (DBS) of the nucleus accumbens (NAc) shows first promising results in patients with severe substance use disorder (SUD), a patient group known to have deficits in self-control. One facet of self-control is the ability to forego smaller sooner rewards in favor of larger later rewards (delay discounting, DD). The NAc has been suggested to integrate motivational

2018 Brain sciences PubMed abstract

65. A Systematic Review of Attention Biases in Opioid, Cannabis, Stimulant Use Disorders (Full text)

A Systematic Review of Attention Biases in Opioid, Cannabis, Stimulant Use Disorders Background: Opiates, cannabis, and amphetamines are highly abused, and use of these substances are prevalent disorders. Psychological interventions are crucial given that they help individuals maintain abstinence following a lapse or relapse into substance use. Advances in experimental psychology have suggested that automatic attention biases might be responsible for relapse. Prior reviews have provided (...) evidence for the presence of these biases in addictive disorders and the effectiveness of bias modification. However, the prior studies are limited, as they failed to include trials involving participants with these prevalent addictive disorders or have failed to adopt a systematic approach in evidence synthesis. Objectives: The primary aim of this current systematic review is to synthesise the current evidence for attention biases amongst opioid use, cannabis use, and stimulant use disorders

2018 International journal of environmental research and public health PubMed abstract

66. A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD). (Abstract)

A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD). Randomised and sham-controlled trials (RCTs) of repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) have yielded conflicting results, which may be due to the variability in rTMS parameters used. We performed an updated systematic review and meta-analysis (...) on the effectiveness of rTMS for the treatment of OCD and aimed to determine whether certain rTMS parameters, such as cortical target, may be associated with higher treatment effectiveness. After conducting a systematic literature review for RCTs on rTMS for OCD through to 1 December 2016 using MEDLINE, PubMed, Web of Science, PsycINFO, Google, and Google Scholar, we performed a random-effects meta-analysis with the outcome measure as pre-post changes in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores

2018 The Psychiatric quarterly

67. Managing opioid use disorder in primary care: PEER simplified guideline

that, similar to other chronic diseases, management of OUD be performed in primary care as part of the continuum of care for patients with OUD. Diagnosis of OUD The diagnostic criteria in the DSM-IV and DSM-5 are the Table 1. Estimated effects of treatments in opioid use disorder with GRADE rating of evidence TOPIC INTERVENTION VS CONTROL OUTCOME ESTIMATED BENEFIT, % FOLLOW-UP RANGE NNT OR NNH GRADE QUALITY OF EVIDENCE INTERVENTION CONTROL Primary care Primary care vs specialty care Treatment retention 86 (...) in male patients -Methadone can cause sweating, which can also be a withdrawal symptom • For patients with chronic pain, first stabilize the OUD before managing pain -Pain outcomes might improve as OUD stabilizes • OAT can still be used in the context of polysubstance use disorder (eg, OUD and stimulant use disorder) • If patients are employed in safety-sensitive jobs, check employer standards for urine drug testing and pharmacotherapeutic management • If a urine drug test result is negative

2019 CPG Infobase

68. Opioid use disorder

Opioid use disorder Opioid use disorder - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Opioid use disorder Last reviewed: February 2019 Last updated: January 2019 Summary Heroin and prescription opioid misuse is a major health concern. From a diagnostic perspective, it is imperative that the physician understands the criteria for opioid use disorder. Comorbid medical and psychiatric illnesses, as well as other (...) substance use disorders, should be assessed. Physicians should be aware of methods for screening and detection of opioid use in clinical settings. Evidence-based treatments include detoxification, maintenance therapy, and psychosocial and supportive therapies. Treatment requires a multidisciplinary approach, is long term, and involves modifying deeply ingrained behaviours through the use of medications and psychosocial treatments. Definition An opioid is a synthetic or natural agent that stimulates

2019 BMJ Best Practice

69. Canadian guidelines on opioid use disorder among older adults

and rarely > 7 days. [GRADE Quality: Moderate; Strength: Strong] RECOMMENDATION #2: In most circumstances, avoid prescribing opioids for older adults with CNCP . For severe pain that is not responsive to non- opioid therapy in patients without a history of substance use disorder and without active mental illness, a trial of opioid treatment may be considered. Consider obtaining a second opinion before prescribing long-term opioid therapy. After explaining the risks and benefits to the patient, prescribe (...) , with an emphasis on signs of intoxication or withdrawal and the sequelae of substance use. Laboratory and other investigations (including urine drug tests) should be performed as appropriate for the medical conditions identified. Reassessment is essential and should be conducted episodically throughout long-term care. [GRADE Quality: Moderate; Strength: Strong]7 Canadian Guidelines on Opioid Use Disorder Among Older Adults QUESTION E: In older adults with or at risk for an OUD, what considerations

2019 CPG Infobase

70. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients with Parkinson's Disease

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients with Parkinson's Disease cns.org ');//]]> × To support the neurosurgery community in these unprecedented times, the CNS is offering complimentary online education. . Register today for the only neurosurgery meeting you can’t miss! Register today for the only neurosurgery meeting you can’t miss! Register today (...) for the only neurosurgery meeting you can’t miss! Register today for the only neurosurgery meeting you can’t miss! Register today for the only neurosurgery meeting you can’t miss! We're Sorry. We cannot find the page you requested. The file you are looking for may have been moved. You can or . The CNS Mission: Enhancing health and improving lives through the advancement of neurosurgical education and scientific exchange Get Involved Associated CNS Websites Connect With Us 10 North Martingale Road, Suite

2017 Congress of Neurological Surgeons

71. Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis. (Abstract)

Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis. Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) has been proposed as a treatment strategy for gait disorder in patients with Parkinson's disease (PD). We thus performed a systematic review and meta-analysis of randomized and nonrandomized controlled trials to assess the effect of this treatment on gait disorder in patients with PD. We (...) systematically searched PubMed, Cochrane, Web of Knowledge, Wan Fang and WIP for randomized and nonrandomized controlled trials (published before July 29, 2014; no language restrictions) comparing PPN-DBS with other treatments. We assessed pooled data using a random effects model and a fixed effects model. Of 130 identified studies, 14 were eligible and were included in our analysis (N = 82 participants). Compared to those presurgery, the Unified Parkinson Disease Rating Scale (UPDRS) 27-30 scores

2020 Neurochemical Research

72. Systematic review with meta-analysis: Stimulant medication for ADHD not associated with subsequent substance use disorders

Systematic review with meta-analysis: Stimulant medication for ADHD not associated with subsequent substance use disorders Stimulant medication for ADHD not associated with subsequent substance use disorders | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Stimulant medication for ADHD not associated with subsequent substance use disorders Article Text Aetiology Systematic review with meta-analysis Stimulant medication for ADHD

2014 Evidence-Based Medicine

73. Letter to the editor: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Patients with Failed Back Surgery Syndrome (Full text)

Letter to the editor: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Patients with Failed Back Surgery Syndrome 28874987 2018 11 13 1976-1902 11 4 2017 Aug Asian spine journal Asian Spine J Letter to the editor: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Patients with Failed Back Surgery Syndrome. 675-676 10.4184/asj.2017.11.4.675 Scalone Luciana L Research Centre on Public Health, University

2017 Asian spine journal PubMed abstract

74. Response to: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Failed Back Surgery Syndrome (Full text)

Response to: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Failed Back Surgery Syndrome 28874988 2018 11 13 1976-1902 11 4 2017 Aug Asian spine journal Asian Spine J Response to: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Failed Back Surgery Syndrome. 677-678 10.4184/asj.2017.11.4.677 Waszak Przemyslaw Maciej PM Janusz Korczak Memorial Voivodeship Hospital, Słupsk, Poland. Department of Hygiene

2017 Asian spine journal PubMed abstract

75. Early initiation of amphetamine-type stimulants (ATS) use associated with lowered cognitive performance among individuals with co-occurring opioid and ATS use disorders in Malaysia. (Full text)

Early initiation of amphetamine-type stimulants (ATS) use associated with lowered cognitive performance among individuals with co-occurring opioid and ATS use disorders in Malaysia. Amphetamine-type stimulants (ATS) use is increasingly prevalent in Malaysia, including among individuals who also use opioids. We evaluated cognitive functioning profiles among individuals with co-occurring opioid and ATS dependence and their lifetime patterns of drug use. Participants (N = 50) enrolling (...) of the developing brain to stimulant and/or neurotoxic effects of these drugs, the current study findings cannot preclude lowered cognitive performance before initiation of ATS use.

2017 Journal of psychoactive drugs PubMed abstract

76. The 2020 appropriate use criteria for chronic lower extremity venous disease

The 2020 appropriate use criteria for chronic lower extremity venous disease The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology - Journal of Vascular Surgery: Venous and Lymphatic Disorders Email/Username: Password: Remember me Search JVS Journals Search Terms Search within Search To read this article in full, please (...) review your options for gaining access at the bottom of the page. Article in Press The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology Presented at the Thirty-first Annual Meeting of the American Venous Forum, Rancho Mirage, Calif, February 19-22, 2019. x Elna Masuda Affiliations Straub Medical Center, Hawaii Pacific Health

2020 American Venous Forum

77. Interventions for Substance Use Disorders in Adolescents: A Systematic Review

abstinence. ? More research is needed to understand the role of medications in treatment of alcohol and cannabis use disorders and of pharmacological treatments typically used for comorbid psychiatric illnesses. • College students with problematic alcohol use o Behavioral interventions ? Mandated alcohol programs decrease alcohol use in the medium term, regardless of intervention. Four commercially available interventions are more effective in the short term than no intervention. ? Brief behavioral (...) Introduction Background and Objectives In 2017, in the United States, an estimated 992,000 adolescents aged 12 to 17 (4% of the adolescent population) and 5.1 million young adults aged 18 to 25 (14.8% of the young adult population) met diagnostic criteria for a substance use disorder (SUD). 1 Thus, about 1 in 25 adolescents and 1 in 7 young adults had a diagnosable SUD. The vast majority were untreated, with fewer than 1 in 10 adolescents or young adults with a diagnosable condition receiving specialty

2020 Effective Health Care Program (AHRQ)

78. Effectiveness of multisensory stimulation in managing neuropsychiatric symptoms in older adults with major neurocognitive disorder: a systematic review. (Abstract)

Effectiveness of multisensory stimulation in managing neuropsychiatric symptoms in older adults with major neurocognitive disorder: a systematic review. The objective of the review was to synthesize the effectiveness of multisensory stimulation in managing neuropsychiatric symptoms (NPS) in older adults with major neurocognitive disorder (NCD).Major neurocognitive disorder is characterized by changes in specific cognitive domains with a progressive deterioration in cognitive ability (...) and capacity for independent living. Most older adults with this condition have one or more concomitant symptoms known as NPS. Evidence shows that nonpharmacological therapies have been effective in controlling these symptoms, with multisensory stimulation attracting further investigation.The review considered studies on older adults aged 65 years or over with major NCD. The intervention of interest was multisensory stimulation, and the comparator was usual care (e.g. no occupational therapy, no cognitive

2019 JBI database of systematic reviews and implementation reports

79. Amfetamine use disorder

Amfetamine use disorder Amfetamine use disorder - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Amfetamine use disorder Last reviewed: February 2019 Last updated: November 2018 Summary Amfetamines have certain therapeutic uses, but misuse potential is high. No medication has proven effective in breaking the misuse cycle. Aggressive psychological and sociological interventions are needed to reduce the high recidivism (...) rate. Definition Amfetamine use disorder involves the recreational use (other than for an approved medical indication) of a class of non-catecholamine sympathomimetic amines - specifically, amfetamines, metamfetamines, and 3,4-methylenedioxymethamfetamine (MDMA, also known as ecstasy), misused by oral and intravenous routes, nasal insufflation (snorting) and inhalation (smoking), resulting in either acute or chronic toxicity. Although these compounds have been used to improve alertness, enhance

2018 BMJ Best Practice

80. Overview of substance use disorders and overdose

Overview of substance use disorders and overdose Overview of substance use disorders and overdose - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of substance use disorders and overdose Last reviewed: February 2019 Last updated: November 2018 Introduction According to the United Nations Office on Drugs and Crime (UNODC), it is estimated that 1 in 20 adults, or a quarter of a billion people between the ages (...) , both occasionally and regularly, tend to be polydrug users who use more than one substance concurrently or sequentially. United Nations Office on Drugs and Crime. World drug report 2016. May 2016 [internet publication]. https://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf Related conditions Condition Description An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opiates are opioids that are naturally derived from the opium poppy

2018 BMJ Best Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>